An Open-Label Pilot Study to Assess the Safety of Oral Lacosamide as Adjunctive Therapy for Unvontrolled Primary Generalized Tonic-Clonic Seizures in Subjects with Idiopathic Generalized Epilepsy (SP0961)

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/109/30/11

Funding

  • Schwarz BioSciences Inc: $2.00